Cite
APA Citation
Verstovsek, S., Savona, M. R., Mesa, R. A., Dong, H., Maltzman, J. D., Sharma, S., Silverman, J., Oh, S. T., & Gotlib, J. (2017). a phase 2 study of simtuzumab in patients with primary, post‐polycythaemia vera or post‐essential thrombocythaemia myelofibrosis. British journal of haematology, 176, 939–949. http://access.bl.uk/ark:/81055/vdc_100042871576.0x000057